Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
| Product: | Ibrance |
| Active Ingredient: | Palbociclib 75mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturer: | Pfizer Manufacturing Deutschland GmbH, Freiburg Im Breisgau, Germany |
| Product: | Ibrance |
| Active Ingredient: | Palbociclib 75mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturer: | Pfizer Manufacturing Deutschland GmbH, Freiburg Im Breisgau, Germany |
| Product: | Ibrance |
| Active Ingredient: | Palbociclib 100mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturer: | Pfizer Manufacturing Deutschland GmbH, Freiburg Im Breisgau, Germany |
| Product: | Ibrance |
| Active Ingredient: | Palbociclib 100mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturer: | Pfizer Manufacturing Deutschland GmbH, Freiburg Im Breisgau, Germany |
| Product: | Ibrance |
| Active Ingredient: | Palbociclib 125mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturer: | Pfizer Manufacturing Deutschland GmbH, Freiburg Im Breisgau, Germany |
| Product: | Ibrance |
| Active Ingredient: | Palbociclib 125mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturer: | Pfizer Manufacturing Deutschland GmbH, Freiburg Im Breisgau, Germany |
| Product: | Palbociclib Pfizer |
| Active Ingredient: | Palbociclib 75mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturer: | Pfizer Manufacturing Deutschland GmbH, Freiburg Im Breisgau, Germany |
| Product: | Palbociclib Pfizer |
| Active Ingredient: | Palbociclib 100mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturer: | Pfizer Manufacturing Deutschland GmbH, Freiburg Im Breisgau, Germany |
| Product: | Palbociclib Pfizer |
| Active Ingredient: | Palbociclib 125mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturer: | Pfizer Manufacturing Deutschland GmbH, Freiburg Im Breisgau, Germany |
| Product: | Ultraproct |
| Active Ingredients: | Cinchocaine hydrochloride 5mg/g Fluocortolone hexanoate 0.945mg/g Fluocortolone pivalate 0.918mg/g |
| Dosage Form: | Topical ointment |
| New Zealand Sponsor: | AFT Pharmaceuticals Limited |
| Manufacturers: | Temmler Italia S.r.l., Milano, Italy Leo Pharma Manufacturing Srl, Milano, Italy |
| Product: | Ultraproct |
| Active Ingredients: | Cinchocaine hydrochloride 1mg Fluocortolone hexanoate 0.63mg Fluocortolone pivalate 0.612mg |
| Dosage Form: | Suppository |
| New Zealand Sponsor: | AFT Pharmaceuticals Limited |
| Manufacturer: | Istituto de Angeli SrL, Florence, Italy |
| Product: | Venclexta |
| Active Ingredient: | Venetoclax 10mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | AbbVie Limited |
| Manufacturers: | AbbVie Ireland NL B.V., Sligo, Ireland Fournier Laboratories Ireland Limited, Carrigtwohill, Ireland |
| Product: | Venclexta |
| Active Ingredient: | Venetoclax 50mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | AbbVie Limited |
| Manufacturers: | AbbVie Ireland NL B.V., Sligo, Ireland Fournier Laboratories Ireland Limited, Carrigtwohill, Ireland |
| Product: | Venclexta |
| Active Ingredient: | Venetoclax 100mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | AbbVie Limited |
| Manufacturers: | AbbVie Ireland NL B.V., Sligo, Ireland Fournier Laboratories Ireland Limited, Carrigtwohill, Ireland |
| Product: | Venclexta (Combination pack) |
| Component 1: | |
| Active Ingredient: | Venetoclax 10mg |
| Dosage Form: | Film coated tablet |
| Component 2: | |
| Active Ingredient: | Venetoclax 50mg |
| Dosage Form: | Film coated tablet |
| Component 3: | |
| Active Ingredient: | Venetoclax 100mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | AbbVie Limited |
| Manufacturers: | AbbVie Ireland NL B.V., Sligo, Ireland Fournier Laboratories Ireland Limited, Carrigtwohill, Ireland |
Dated this 2nd day of April 2026.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).